You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Study of factors associated with recurrence. Bi-variable analyses between host factors, primary cyst and treatment used with recurrence

From: Recurrence of cystic echinococcosis in an endemic area: a retrospective study

Patients with recurrences n/N (%) OR (IC95%) p-value*
Host factors
 Age ≤ 59 years 17/124 (13.7) 1.6 (0.6–4.0) 0.244
 Male sex 18/133 (13.5) 1.7 (0.6–4.3) 0.243
 Patients from rural areas 17/148 (11.5) 0.9 (0.4–2.4) 0.982
 Professional activity-agriculture/livestock 2/31 (6.5) 0.4 (0.1–2.1) 0.340
 Contact with animals 4/60 (6.7) 0.4 (0.1–1.4) 0.166
 Immigrants 0/6 (0.0)
 Comorbidity 7/73 (9.6) 0.7 (0.2–1.8-) 0.526
Cyst primary factors
 Complicated 9/88 (10.2) 0.8 (0.3–1.9) 0.622
 Cyst size (≥7 cm) 16/122 (13.1) 1.4 (0.6–3.4) 0.405
Cyst location
 Liver  Lung  Others/disseminated 19/193 (9.8) 0/12 (0.0) 7/31 (22.6) 0.3 (0.1–0.9) – 2.7 (1.1–7.1) 0.028* – 0.037*
No. of cysts (≥2) 11/80 (13.8) 1.4 (0.6–3.2) 0.432
WHO classification  CE1  CE2  CE3  CE4  CE5 19/193 (9.8) 0/10 (0.0) 8/59 (13.6) 4/32 (12.5) 2/30 (6.7) 5/62 (8.1)   0.587
Factors associated to treatment
 Combinated treatment (Antihelminths & surgical) 20/141 (14.2) 2.3 (1.4–6.5) 0.094
 Surgical technics 5/76 (6.6)
 Surgical treatment complications 7/38 (18.4) 2.0 (0.7–5.2) 0.142
  1. *p-value of the test: Total patients with treatment with curative intention-follow-up & Recurrences. Statistical significance level of 5% (p < 0.05)